ArticleDiabetes2010

The glucagonostatic and insulinotropic effects of glucagon-like peptide 1 contribute equally to its glucose-lowering action.

Kristine J Hare et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.